Kingdee International Gains Over 4% Before Noon as Everbright Securities Keeps Buy Rating

Deep News
Yesterday

Kingdee International (00268) rose more than 5% during intraday trading. As of press time, the stock was up 4.06%, trading at HK$7.43, with a turnover of HK$109 million.

People familiar with the matter revealed that Lingee, Kingdee International's enterprise AI agent operating system, has been deployed by more than 3,000 customers, and demand for Kingdee International's enterprise-level AI products is currently strong. In addition, Kingdee Lingee passed the China Academy of Information and Communications Technology's trusted AI enterprise-level AI-native office agent platform capability assessment, reaching a 4+ rating, becoming one of the first products in China to pass this assessment and obtain the current highest rating.

Everbright Securities previously released a research report stating that Kingdee focuses on subscription-first and AI-first strategies, and the company is accelerating the commercialization of AI-native products. Considering the revenue boost from AI-native products, it slightly raised its 2026-2027 revenue forecasts to 7.9 billion yuan and 9 billion yuan, and added a 2028 revenue forecast of 10.2 billion yuan; it maintained its 2026-2027 net profit attributable to shareholders forecasts and added a 2028 net profit attributable to shareholders forecast of 1.2 billion yuan. As a leading domestic ERP player, Kingdee International's product strength is expected to be further enhanced with AI support, and the Buy rating is maintained.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10